Conversely, the high‐risk group exhibited upregulation in pathways linked to allograft rejection, cytokine‐cytokine receptor interaction, graft versus host disease, intestinal immune network for IgA production and type I diabetes mellitus (Figure 10A,B). This evidence concerns the gene CD79A and type 1 diabetes mellitus.